OptimizeRx (OPRX) PT Raised to $11 at Citizens: Positioned for Return to Growth in 2027
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Citizens raises OPRX target to $11 on expected growth in 2027.
Target: $11
Posted price: $8.78
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.